Ligand Pharmaceuticals Incorporated (LGND) vs Rhythm Pharmaceuticals, Inc. (RYTM)
A side-by-side comparison of Ligand Pharmaceuticals Incorporated and Rhythm Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LGND
Ligand Pharmaceuticals Incorporated
$296.60HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
RYTM
Rhythm Pharmaceuticals, Inc.
$90.84HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — LGND vs RYTM
growth of $100 · dividends reinvested · last 9yLGND +265.1% (+15.5%/yr)RYTM +208.2% (+13.3%/yr)LGND compounded faster over this window
LGND RYTM
LGND vs RYTM: by the numbers
- •RYTM is the larger company ($6.23B vs $5.94B market cap).
- •LGND is profitable (67.88% net margin) while RYTM runs a net loss (-85.59%).
- •RYTM grew revenue faster over the past five years (278.53% vs 2.92% CAGR).
Metrics side by side
Valuation
| Metric | LGND | RYTM |
|---|---|---|
| P/E ratio | 31.72 | N/A |
| Forward P/E | 31.87 | N/A |
| P/S ratio | 20.46 | 25.97 |
| P/B ratio | 6.14 | 60.50 |
| EV / EBITDA | 44.97 | N/A |
| FCF yield | 2.21% | N/A |
Profitability
| Metric | LGND | RYTM |
|---|---|---|
| Gross margin | 98.58% | 89.00% |
| Operating margin | 17.61% | -101.19% |
| Net margin | 67.88% | -85.59% |
| ROE | 20.38% | -94.50% |
| ROIC | 3.91% | -63.96% |
Growth (annualized)
| Metric | LGND | RYTM |
|---|---|---|
| Revenue CAGR (5Y) | 2.92% | 278.53% |
| FCF CAGR (5Y) | -0.49% | N/A |
| Total return CAGR (5Y) | 30.72% | 49.95% |
Frequently asked
- Which has grown faster, LGND or RYTM?
- Over the past five years, RYTM grew revenue faster — LGND at a 2.92% CAGR versus RYTM at 278.53%.
- Is LGND or RYTM more profitable?
- LGND runs the higher net margin — LGND at 67.88% versus RYTM at -85.59%.
- How have LGND and RYTM total returns compared?
- Over the past 5 years, LGND delivered 30.72% and RYTM delivered 49.95% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Ligand Pharmaceuticals P/E ratioLigand Pharmaceuticals ROERhythm Pharmaceuticals ROELigand Pharmaceuticals operating marginRhythm Pharmaceuticals operating marginLigand Pharmaceuticals revenue growthRhythm Pharmaceuticals revenue growthLigand Pharmaceuticals free cash flowRhythm Pharmaceuticals free cash flow
Ligand Pharmaceuticals & Rhythm Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.